# Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

> **NCT00913458** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 306 (actual)

## Conditions studied

- Active Rheumatoid Arthritis
- Arthritis, Rheumatoid
- Rheumatoid Arthritis

## Interventions

- **DRUG:** etanercept

## Key facts

- **NCT ID:** NCT00913458
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-12
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2014-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913458, "Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00913458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*